Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8+ T cell activation and limit responsiveness to immunotherapy in mice
Authors:
Open Access
- 22 July 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Abstract
Senescent cells within tumors and their stroma exert complex pro- and anti-tumorigenic functions. However, the identities and traits of these cells, and the potential for improving cancer therapy through their targeting, remain poorly characterized. Here, we identify a senescent subset within previously-defined cancer-associated fibroblasts (CAFs) in pancreatic ductal adenocarcinomas (PDAC) and in premalignant lesions in mice and humans. Senescent CAFs isolated from mouse and humans expressed elevated levels of immune-regulatory genes. Depletion of senescent CAFs, either genetically or using the Bcl-2 inhibitor ABT-199 (venetoclax), increased the proportion of activated CD8+ T cells in mouse pancreatic carcinomas, whereas induction of CAF senescence had the opposite effect. Combining ABT-199 with an immune checkpoint therapy regimen significantly reduced mouse tumor burden. These results indicate that senescent CAFs in PDAC stroma limit the numbers of activated cytotoxic CD8+ T cells, and suggest that their targeted elimination through senolytic treatment may enhance immunotherapy.Keywords
This publication has 51 references indexed in Scilit:
- Senescent alveolar macrophages promote early-stage lung tumorigenesisCancer Cell, 2023
- Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancerCancer Cell, 2023
- Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancerCancer Cell, 2023
- Spatially confined sub-tumor microenvironments in pancreatic cancerCell, 2021
- Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunityCancer Cell, 2021
- Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerCell, 2020
- Cellular Senescence: Defining a Path ForwardCell, 2019
- Senescence in Health and DiseaseCell, 2017
- Identification of Sox9-Dependent Acinar-to-Ductal Reprogramming as the Principal Mechanism for Initiation of Pancreatic Ductal AdenocarcinomaCancer Cell, 2012
- Pancreatitis-Induced Inflammation Contributes to Pancreatic Cancer by Inhibiting Oncogene-Induced SenescenceCancer Cell, 2011